Express News | Cardiff Oncology Inc: Announces New Patent With Claims for Use of Onvansertib in Treating Kras Mutated Mcrc
Here's Why We're Watching Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Situation
Daily Options Tracker | Tesla options volume surges! Bullish call up to $400; Cryptocurrency stocks skyrocket! MSTR one call option earns 54 times profit.
The volume of MARA options exceeded 0.9 million contracts, increasing more than twofold compared to the previous period, with a call ratio as high as 80%. The implied volatility rose by 38% to a relatively high level for the year, and both Coinbase and microstrategy have call ratios above 70%.
Cardiff Oncology Reports Positive Q3 2024 Results and Clinical Progress
Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.
Cardiff Oncology Shares Are Trading Lower. The Company Reported Q3 Financial Results.